524661 — Welcure Drugs and Pharmaceuticals Income Statement
0.000.00%
Last trade - 00:00- IN₹65.80m
- IN₹65.41m
Annual income statement for Welcure Drugs and Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | R2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | Interim Report |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.795 | 0.825 | 1.33 | 1.05 | 0 |
| Cost of Revenue | |||||
| Gross Profit | — | — | — | — | 0 |
| Selling / General / Administrative Expenses | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 0.772 | 0.923 | 0.784 | 0.814 | 1.22 |
| Operating Profit | 0.023 | -0.098 | 0.549 | 0.236 | -1.22 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 0.039 | -0.094 | 0.551 | 0.236 | -0.526 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 0.039 | -0.094 | 0.551 | 0.236 | -0.526 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 0.039 | -0.094 | 0.551 | 0.236 | -0.526 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 0.039 | -0.094 | 0.551 | 0.236 | -0.526 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.003 | -0.008 | 0.045 | 0.019 | -0.004 |